ABR-217620 With Interferon-alpha (IFN-alpha) Compared to IFN-alpha Alone in Patients With Advanced Renal Cell Carcinoma

The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2011 by Active Biotech AB.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by (Responsible Party):
Active Biotech AB
ClinicalTrials.gov Identifier:
NCT00420888
First received: January 9, 2007
Last updated: October 21, 2011
Last verified: October 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2012
  Estimated Primary Completion Date: June 2012 (Final data collection date for primary outcome measure)